ImpediMed Gains FDA Clearance for SOZO Sarcopenia Assessment
CARLSBAD, Calif., August 18, 2026 ImpediMed announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance...
FDA clearance
Advertisement
Intelligent Bio Solutions Gains ISO Recertification
New York, August 17, 2026 Intelligent Bio Solutions Inc. announced that its Intelligent Fingerprinting Drug Screening business has received...
Photocure Advances FDA Reclassification of Blue Light Cystoscopy
Oslo, Norway, August 14, 2026 Photocure ASA has welcomed a new proposal from the U.S. Food and Drug Administration...
Aidoc Secures Medicare Payment for AI Body CT Triage
New York, New York, August 13, 2026 Aidoc announced that its CARE™ Body CT Multi-Triage has received eligibility for...
QIAGEN Gains FDA Clearance for Bloodstream Infection Testing
Germantown, Maryland, and Venlo, Netherlands, August, 10, 2026 QIAGEN has received U.S. Food and Drug Administration (FDA) clearance for...
Advertisements
BlueWind Medical Wins FDA Clearance for Revi Extend Implant
Salt Lake City, Utah, August 6, 2026 BlueWind Medical, Ltd. has received U.S. Food and Drug Administration (FDA) 510(k)...
BriaCell Secures FDA Clearance for Prostate Cancer Therapy
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 5, 2026 BriaCell Therapeutics Corp. has received U.S. Food and Drug Administration (FDA)...
Meitheal Gains FDA Approval for Garzulys Insulin Biosimilar
Chicago, Illinois – August 3, 2026 Meitheal Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has...
Akebia Launches Phase 2 Ebribafusp Trial in Kidney Diseases
Cambridge, Massachusetts, August 3, 2026 Akebia Therapeutics, Inc. announced the initiation of an open-label Phase 2 basket trial of...
Intelligent Bio Solutions Advances FDA 510(k) Drug Screening Study
New York, August 3, 2026 Intelligent Bio Solutions Inc. (INBS) announced the completion of an Interference Study for its...
Advertisement
